Saab 9-3 some revisions in 2011 for the 2012 model year. Changes were in the engine range with an overall reduction in diesel and petrol engine fuel consumption of 12% and 7% respectively. An entry-level 163 hp, 2.0-litre gasoline / BioPower engine was added for 9-3 saloon, estate, and 9-3X models with Saab XWD. Other changes included rear badging in line with all new Saab 9-5 saloon, 'ice block' style headlights, New bumper design, titanium metallic effect trim around instrument panel, gearshift, doors and glove box. Aero gets graphite fiber effect. Contrast stitching on leather upholstery. In most markets, car was badged
7+3 (chemotherapy) doxorubicin or idarubicin or mitoxantrone). There were attempts to intensify the "7+3" regimen in order to try to improve its efficacy. Attempts were made to prolong the course (cytarabine for 10 days instead of 7, or daunorubicin/idarubicin for 4–5 days instead of 3). On the other hand, there were attempts to minimize the toxicity of the regimen by reducing the dose or the duration of the course. But this proved to compromise the efficacy of the regimen. The addition of vinca alkaloids (vincristine or vinblastine) to the "7+3" regimen, which addition was quite popular in AML in old times (when